Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Corflow Therapeutics AG maintains 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This action is distributed to 1 distinct examiner and 1 distinct art unit, indicating a very focused prosecution presence at the patent office. The involvement of only 1 examiner suggests that the company's current filings are concentrated on a specific medical device or mechanical innovation.
The busiest examiner identified is HALL, DEANNA K, who is currently responsible for 1 pending office action. Since the total pending office actions for the company is 1, this examiner handles the entirety of the active workload. This 1 to 1 ratio between the busiest examiner's load and the total pending actions reflects a streamlined interaction where the company's immediate success depends on the review of HALL, DEANNA K.
For practitioners, the presence of 1 distinct art unit and 1 distinct examiner for the 1 pending office action provides a clear and direct path for prosecution. There are no competing examination styles or different unit standards to navigate, as all current activity is centralized. This focused profile in the Medical Devices & Mechanical Engineering sector allows the applicant to dedicate all resources to resolving the issues raised in the single pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HALL, DEANNA K | 1 | 75.7% | +15.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18634528 | SYSTEM AND METHODS FOR TREATING MVO | HALL, DEANNA K | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18634528 | SYSTEM AND METHODS FOR TREATING MVO | HALL, DEANNA K | 3783 | §112DP | Non-Final OA | — | Pending | Apr 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial